Janssen wants you to help us ‘hatch’ a plan to improve Australia’s health. HaTCH is looking for innovation that will inspire Australians to better connect with their own health and wellbeing. We would love to see innovation that: • Improves access to and sharing of health information • Transforms healthcare from an individual endeavour into a journey more closely connected to others • Grabs people’s attention and make them want to actively manage their health and wellbeing at every stage of their life In Australia, in line with the National Health Priorities, we need more innovation in the areas of: • Obesity • Drug and alcohol abuse • Mental health SUBMIT YOUR ENTRY AT JANSSENHATCH.COM.AU

1. Inspiring Innovation
in Australian Healthcare
“ The best way to predict the future is to invent it” Alan Kay

2. About the 2014 HaTCH Challenge
Janssen wants you to help us ‘hatch’ a plan to improve Australia’s health.
Created by Janssen Australia, HaTCH, is about creating a better future for healthcare in Australia. We believe in innovation; one bold idea is all it takes to make a difference. If you
have a great idea incubating, and you want to change healthcare as we know it, then enter today and help us create a healthier future for Australia.
HaTCH is looking for innovation that will inspire Australians to better connect with their own health and wellbeing. We would love to see innovation that:
• Improves access to and sharing of health information
• Transforms healthcare from an individual endeavour into a journey more closely connected to others
• Grabs people’s attention and make them want to actively manage their health and wellbeing at every stage of their life
In Australia, in line with the National Health Priorities, we need more innovation in the areas of:
• Obesity
• Drug and alcohol abuse
• Mental health
Additionally, Janssen is interested to see how new innovations discovered in HaTCH can also intersect in therapeutic areas of diabetes, mental health, oncology, virology and
immunology.
Anyone can enter the challenge
HaTCH gives health entrepreneurs, start-ups and community organisations some critical investment to drive growth and innovation in Healthcare. 2014 is the inaugural year of
HaTCH and we can’t wait to see what Australia’s healthpreneurs have to show us. By the end of the competition (Dec 2014), organisations will ideally have a Minimum Viable Product
(MVP) and ideally be at growth stage.
As a member of Australia’s healthcare community Janssen wants to support the next generation of Australian innovation in this space.

3. The Prize*
• 4 finalists to each receive $10,000
• Finalists will collaborate with industry experts to workshop their ideas and business plans
• A single winner will then be chosen to receive $100,000 to kick-start commercialisation of their idea
*Please refer to terms and conditions for full details and conditions relating to the prize

4. The HaTCH Brief
People are living longer but they’re not always living healthier. Chronic disease now places a significant strain on our healthcare system and our community. By 2020 we will be
facing unprecedented demand for care for our aging population proportion of people with life limiting illness.
Local healthcare experts are suggesting that:
• Australia needs more programs to manage health issues outside of hospital
• If we can reduce the number of hospitalisations we will help with the rising cost of healthcare
• If we improve the transitions between hospital and community based care we can reduce the burden on the system. This might happen through better monitoring in the
community, better information sharing and better connectedness to service
So this got Janssen thinking… how about we ‘hatch’ a plan to improve Australia’s health.
We are looking to inspire Australians to better connect with their healthcare.
HaTCH is seeking entries from start-ups, entrepreneurs, and organisations that have developed commercially viable new ideas to help keep Australians healthier, happier and out of
hospital for as long as possible.
HaTCH aims to support the healthcare start up community with funding to develop BREAKTHROUGH innovation that is unique and relevant to the needs of the Australian healthcare
system.

5. What is the HaTCH vision of success?
Innovation that makes being healthier fun and exciting again! Specifically:
• A measurable improvement in the quality of lives of a patient cohort outside of hospital
• A healthier Australian community who can be supported in their homes for longer
• A reduction in the average number of hospital admissions per year of patients with chronic diseases
• An innovation that is commercial viable to ensure its sustainability
Suggested areas of focus
• As a country the challenge is particularly relevant in the areas of obesity, drug and alcohol abuse and mental health.
• As a company, Janssen is interested in how these areas intersect with diabetes, mental health, oncology, virology and immunology.

6. The Judging Process
At HaTCH we know that ideas don’t turn into commercial opportunities all by themselves. You need expertise, experience and strong industry connections.
Raw Innovation will facilitate the judging process to select the top 4 ideas to progress through to final stage of the competition.
The judging panel will judge all entries based on the following criteria (including but not limited to):
a. Applicability to the challenge
b. Quality of the identified need and target market
c. Scalability to meet the needs of a large population in a similar environment
d. Depth of understanding of patients and the healthcare community
e. Ability of the entrant and/or the Promoter to execute the plan
f. Alignment with areas of interest for Australian healthcare and the Promoter’s areas of expertise
g. Clear path to commercialisation
h. The extent to which the initiative proposed is commercially sustainable
i. The extent to which the initiative proposed is a disruptive and innovative approach to the solution
Each finalist team will have the opportunity to workshop their ideas with the mentors during the greenhouse and mentoring day in Sydney.
The finalist mentoring program will include innovation and ideation training, pitch coaching and collaboration with some very senior healthcare experts, doctors and professionals to
put each team in the best possible place for market success.

7. The HaTCH timeline:
Monday 15th September: HaTCH launch
Friday 3rd October: Entry deadline
Tuesday 7th October: Finalists announced
Wednesday 8th October: Finalists awarded $10K cash prize
Thursday 30th October: Greenhouse and mentoring day in Sydney
Tuesday 2nd December: Finalist pitch day
Wednesday 3rd December: Winner announced

8. Your Entry
Entries should be no more than 2000 words. Please submit entry via online entry page at www.janssenhatch.com.au. Entrants can tackle this brief in whatever way they choose, but
each entry should be structured to address the five criteria. Due to the nature of this competition, please carefully read the Terms and Conditions prior to entering.
What is the idea?
A clear and concise articulation of your idea. Keep it simple. (100 words as a guide)
Insight?
What is the evidence that your idea is needed and will make an impact on Australian
healthcare? Make sure your data is accurate, well sourced and persuasive.
Top Tip: Your insight will sell your idea.(500 words as a guide)
Target Audience?
Who is the target audience for your innovation and how will you connect with
them? (50 words as a guide)
How does it work?
How does your idea work? What is the implementation plan? (1000 words as a
guide). For example:
• Outline the functionality and user journey
• Who are the users? What do they do?
• How will people find out about it?
• What is needed to develop your idea? Money, time, personnel, equipment etc
• Anticipated timeline
• Are there any partners involved, such as healthcare professionals, NGOs, etc?
• What is your commercial business model?
Vision of success and measurement
(350 words as a guide)
• What is your vision of success is for this idea?
• How will we know when we achieve success?
• When and how will you measure it?

9. Panel of Experts
Introducing our five outstanding healthcare and start up expert panelists.
Professor Mukesh Haikerwal AO
AO, M.B.; CH.B., DIP. I.M.C.R.C.S. (ED.), D.R.C.O.G.(DIPLOMA), CERT. J.C.P.T.G.P., D.R.A.N.Z.C.O.G.
Professor Mukesh Haikerwal is a leader and passionate advocate for the use of
technology in the health sector. For 6 years until 2013, Mukesh was the National Clinical
Lead and Head of the Clinical Leadership & Stakeholder Management Unit at Australia’s
the National e-Health Transition Authority (NEHTA). He also worked on the National
Health and Hospital Reform Commission formulating a future vision for Australia’s health
including using eHealth as an enabler.
Mukesh is a General Medical Practitioner in Melbourne and current chair of Council of
the World Medical Association, working on the areas of Medical Ethics, Social and Medical
Affairs and in capacity building and advocating for the need for health and health care as
a wise investment for Nations. Also holding positions; Professor in the School of Medicine
at Flinders University in Adelaide, Chair of the beyondblue National Doctors’ Mental
Health Program, Co-Chair of the Australian Asian Medical Federation and a member of
the Advisory Board of Brain Injury Australia.
Mukesh was awarded the Order of Australia in 2011 for distinguished service to medical
administration, to the promotion of public health through leadership roles with
professional organisations. These positions included being the 19th Federal President
of the Australian Medical Association (AMA), its Federal Vice President and, prior to that
AMA Victorian State President. This saw him responsible for national policy development,
lobbying with federal parliamentarians, co-ordinating activity across the AMA State
entities and representing the AMA and its members nationally and internationally.
Amit Vohra
GBQ, MBA, GAICD, AFACHSM
Amit Vohra is a senior health executive, with a demonstrated record of business success
in the Australian health sector.
With a passion for grassroots-driven and outcome-focused practical solutions, Amit
brings a fresh, entrepreneurial outlook to health policy. He has launched a number
of innovative programs to boost supply of future GPs and is particularly interested in
reducing fragmentation across the health care system.
Amit was CEO General Practice Registrar Australia, the peak representative body for junior
doctors from April 2006 – July 2014 during which time he has expanded the company by
over 500% making it the fastest growing medical membership organization in Australia.
Amit has particular interest in improving health workforce distribution, participation and
efficiency and has sat on a number of commonwealth committees and programs. During
this time he has provided high-level advice across a number of commonwealth programs
netting efficiency gains of over $500 million.
Amit was listed amongst the Top 50 Influential People in General Practice in 2010
by Australian Doctor, and is widely recognised as a thought leader on key national
health system issues. Amit has a Masters in Business and is a graduate member of the
Australian Institute of Company Directors. He is currently finishing his PhD with a focus
on health workforce.

10. Panel of Experts
Chris Hourigan
JANSSEN MANAGING DIRECTOR AUSTRALIA / NEW ZEALAND
Chris was appointed to the position of Managing Director for Janssen Australia & New
Zealand on 1 October 2012, returning to Australia after completing several overseas
postings, the most recent as Managing Director for Janssen Vietnam. Prior to that,
Chris was Business Unit Director for the Janssen New Zealand business and he spent
several years in the USA as Global Marketing Leader for the Psychiatry portfolio.
Chris is member of the Medicines Australia Board and brings a wealth of experience in
the healthcare industry to the judging panel.
Chris’s vision for the pharmaceutical industry in Australia is to ensure the ANZ public
receives access to innovative medicines and also to continue the globally recognised
level of excellence in ANZ’s clinical research activities, which are continually looking for
cures and better methods of disease management.
Cyrus Allen
PARTNER, STRATIVITY GROUP AUSTRALIA & NEW ZEALAND
Cyrus is a senior customer executive with deep consulting and operational experience
across customer strategy, customer experience management, digital, marketing and
service design. As a Partner with Strativity Group, Cyrus builds on 20 years of local and
international experience in senior product, Brand and customer experience roles with
Ericsson, Sony Ericsson, Telstra and most recently ANZ Banking Corporation.
Cyrus works with organisations to improve the experiences they deliver through
defining and implementing customer experience strategies. His work includes Omni-channel
design, experience innovation, customer strategy assessment, Branded
experience design and VOC program development. He holds a Master’s Degree in
Marketing, Bachelor’s Degrees in Business and Arts, and has completed a custom
executive program at AGSM. Cyrus is an adviser to two technology start-ups and serves
as a Board Director for Gowrie Victoria, a leader in early childhood education.

11. Panel of Experts
Mick Liubinskas
HEAD COACH AT MURU-D ACCELERATOR, POLLENIZER CO-FOUNDER, OOMPH DIRECTOR, WOOBOARD CHAIRMAN
Mick Liubinskas is a high energy, technology entrepreneur, advisor, investor and industry leader.
He programmed his Commodore 64 at age 12, sold computer networks at age 17, raised capital
for a business at 22 and ran marketing globally for Kazaa at 26.
For the past 8 years he has co-founded and worked with more than 30 technology startup
companies, including starting Pollenizer with Phil Morle. This has included evaluating ideas,
building first products, launching in the USA, raising angel and venture capital, selling a business
and all the emotional rollercoaster rides in between.
His most successful companies are Oomph which is leading the world in iPad publishing and
Spreets which sold to Spreets for ~$40m in 13 months.
Mick is often known as Mr Focus due to his strong drive for starting small and fast, embracing
failure on the road to success and avoiding the entrepreneurial distractions.
He’s also proud of his role in helping to establish and build the technology entrepreneur industry
in Sydney and Australia, including accidentally founding Silicon Beach Drinks. Master’s Degree
in Marketing, Bachelor’s Degrees in Business and Arts, and has completed a custom executive
program at AGSM. Cyrus is an adviser to two technology start-ups and serves as a Board Director
for Gowrie Victoria, a leader in early childhood education.

12. About the Sponsor
Janssen Pharmaceutical Companies of Johnson & Johnson are dedicated to addressing and solving the most important unmet medical needs of our time,
including oncology (e.g. multiple myeloma and prostate cancer), immunology (e.g. psoriasis), neuroscience (e.g. schizophrenia, dementia and pain), infectious
disease (e.g. HIV/AIDS, Hepatitis C and tuberculosis), and cardiovascular and metabolic diseases (e.g. diabetes).
We have a proud heritage in our founder Dr Paul Janssen who established the company with a strong grounding in science and innovative solutions, always putting patients first.
Driven by our commitment to patients, we develop sustainable, integrated healthcare solutions by working side-by-side with healthcare stakeholders, based on partnerships of trust
and transparency.
More information can be found at www.janssen.com.au

13. SUBMIT YOUR ENTRY AT
JANSSENHATCH.COM.AU TODAY!
Before you submit, please read the terms and conditions and the privacy policy very carefully to ensure you understand and comply with
the terms and conditions of entering the challenge. Both policies can be found at www.janssenhatch.com.au . If your entry is seen to void the
terms and conditions we will be unable to consider you for a prize.

14. HaTCH – Terms and Conditions
1 Information regarding cash awards and how to enter forms part of these conditions. By entering, entrants accept these conditions. Nothing in these conditions restricts, excludes or modifies or purports to restrict,
exclude or modify any statutory consumer rights under any applicable law including the Competition and Consumer Act 2010 (Cth).
2 Entry is open only to Australian residents aged 18 years or older or Australian companies having greater than 51% Australian ownership and that have at least one Board Member who is an Australian resident.
Individual entrants may participate with other entrants as teams, in which case each entrant agrees to be bound by these terms and conditions. Directors, management and employees of the Janssen-Cilag Pty Ltd
(Promoter) and associated companies and agencies involved with the competition as well as the immediate families of each of these people are not eligible to enter.
Phase 1
3 Phase 1 of the competition begins at 9:00 AM on Monday 15th September 2014 and closes at 6:00PM on Friday 3rd October 2014 (Phase 1 Competition Period).
To enter Phase 1 of the competition, entrants must, during the Phase 1 Competition Period submit an Eligible Proposal (see clause 4 below) via the HaTCH website at www.janssenhatch.com.au together with their
personal contact details.
4 An Eligible Proposal is a submission that:
(a) is submitted via the online “Submit An Entry” web form located at www.janssenhatch/submit-an-entry of 2000 words or less (appendices are not included in this word count);
(b) addresses the following questions: What is the idea? What is the insight? Who is the target audience? How does it work? What is the vision of success and measurement? ;
(c) provides innovation in the area of disease prevention and wellness outside of hospital; and addresses the challenge outlined on the Brief page of the website www.janssenhatch.com.au/the-brief being
commercially viable new ideas - with specific interest in innovative solutions in the areas of early detection and monitoring; better connection; and information sharing - to help keep Australians healthier,
happier, and out of hospital for as long as possible.
5 Phase 1 entries must be received by the Promoter during the Phase 1 Competition Period. Each entrant may only enter Phase 1 once.
6 The Promoter’s judging panel (Judging Panel) will review all valid entries received during the Phase 1 Promotion Period. On 7th October 2014, the judging panel will judge all entries based on the following criteria
(including but not limited to):
(a) applicability to the challenge
(b) quality of the identified need and target market
(c) scalability to meet the needs of a large population in a similar environment
(d) depth of understanding of patients and the healthcare community
(e) ability of the entrant and/or the Promoter to execute the plan
(f) alignment with areas of interest for Australian healthcare and the Promoter’s areas of expertise
(g) clear path to commercialisation

15. (h) the extent to which the initiative proposed is commercially sustainable
(i) the extent to which the initiative proposed is a disruptive and innovative approach to the solution
7 The four entries judged to be the best Phase 1 entries will each:
(a) be shortlisted as “Phase 1 Finalists” and will proceed to Phase 2 of the competition; and
(b) receive the opportunity to further develop their Eligible Proposal with the Promoter (including receiving a funding grant of AUD$10,000 in the form of an electronic funds transfer to the Phase 1 Finalist’s
nominated bank account) (Phase 1 Award).
8 In consideration for receiving the award set out in clause 7, each Phase 1 Finalist agrees that during Phase 2 of the promotion, it will not:
(a) during the Phase 2 Competition Period, offer or grant any rights in, or in relation to, all or part of its Eligible Proposal, including any right to develop or commercialise any part of its Eligible Proposal;
(b) during the Phase 2 Competition Period, work with, or offer to work with, any person other than the Promoter, in relation to its Eligible Proposal; and
(c) after the Phase 2 Competition Period for a period of 12 months, offer or grant any rights in, or in relation to, all or part of its Eligible Proposal, including any right to develop or commercialise any part of its Eligible
Proposal, unless it has first offered those rights to the Promoter on the same (or more favourable terms), and the Promoter has not, within 60 days, accepted the Phase 1 Finalist’s offer.
9 The Phase 1 Finalists will be notified by Wednesday 8th October 2014 by phone and email. The funding grant will be transferred to the Phase 1 Finalists by electronic funds transfer on Friday 10th October 2014.
Phase 2
10 Phase 2 of the competition begins at 9:00AM on Thursday 9th October 2014 and closes at 6:00PM on Tuesday 2nd December 2014 (Phase 2 Competition Period).
11 To enter Phase 2 of the competition, Phase 1 Finalists must
(a) by no later than 6:00pm, Friday 28th November 2014, submit via hatch@janssen.com.au a written final proposal being a further development of the Phase 1 Finalist’s Eligible Proposal, that is no longer than 20 A4
pages at size 11 Arial font (excluding appendices);
(b) on Tuesday 2nd December 2014 (Pitch Day), present a 30 minute presentation to the Judging Panel in front of an audience (selected at the discretion of the Promoter), and respond to questions in an additional
question session from the Judging Panel.
12 Each Phase 1 Finalist may only enter Phase 2 once. Phase 1 Finalists are entitled to attend a workshop day on Thursday 30th October 2014 (Workshop Day) with experts, and Promoter personnel, who are selected by
the Promoter.
13 The Promoter’s judging panel will review all valid entries received during the Phase 2 Competition Period. On December 3rd 2014 the judging panel will judge all entries based on the criteria set out in clause 6
14 The entry judged to be the best entry will receive the opportunity to collaborate with the Promoter to further develop their Final Proposal to a “minimal viable product” (MVP) , subject to the “Phase 2 Winner”
entering into a Collaboration Agreement with the Promoter, under which the Promoter will, subject to the terms of that Collaboration Agreement (which will be in the form provided by the Promoter and negotiated
and agreed between the Promoter and the Phase 2 Winner), provide seed funding of AUD$100,000 (Phase 2 Award).
15 Only ONE winner will be selected as the Phase 2 Winner.
16 The Phase 2 Winner will be notified in person at an award ceremony on December 3rd 2014.
17 Transport to and from the Workshop Day, Pitch Day and awards ceremony, and accommodation is not included in the Phase 1 Award. Phase 1 Finalists are required to arrange their own transport and accommodation
in relation to these events. These events will be held in Sydney, Australia with further venue details to be confirmed closer to the relevant dates.

16. Other conditions
18 The total award pool is valued at AUD$140,000.
19 This competition is judged on skill and chance plays no part in determining the winners.
20 The Judging Panel reserves the right not to review appendices to entries. Entrants should ensure that all critical details are included in the main sections of their entries.
21 The Promoter accepts no responsibility for any late, lost, incomplete, incorrectly submitted, delayed, illegible, corrupted or misdirected entries, votes or correspondence, whether due to error, omission, alteration,
tampering, deletion, theft, destruction, transmission interruption, communications failure or otherwise.
22 The Promoter has no control over mobile telephone communications, networks or lines and accepts no responsibility for any problems associated with them, whether due to traffic congestion, technical malfunction
or otherwise.
23 The Promoter is not liable for any consequences of user error including (without limitation) costs incurred.
24 Each entrant is responsible for the entry they submit and responsible for paying any costs associated with entering the competition.
25 Eligible Proposals and Final Proposals must be in English
26 Entries that are found to have been derived from third party work will be considered invalid and, if that entry is successful, any award must be returned to the Promoter. Without limiting the generality of other
conditions, the Promoter reserves the right to take legal action against anyone found to have breached this condition. The Promoter reserves the right in its sole discretion to (i) not consider any entry which is not
in accordance with these conditions of entry; and (ii) to disqualify any individual who the Promoter has reason to believe has breached any of these conditions of entry or engaged in any unlawful or other improper
misconduct calculated to jeopardise the fair and proper conduct of the competition. The Promoter’s legal rights to recover damages and other compensation are reserved.
27 Each entrant warrants and agrees that:
(a) the entrant has created the entry themself, or if in a team, the entrant has created the entry only in conjunction with the other team entrants;
(b) the entrant is entitled to reproduce and exploit all of the underlying works in the entry;
(c) the entrant will not submit material in their entry that is copyrighted, protected by trade secret or otherwise subject to third party proprietary rights, including privacy and publicity rights, unless the entrant is the
owner of such rights;
(d) the entry has not been previously published in any other medium or forum worldwide;
(e) the entrant will not submit material that is unlawful, obscene, defamatory, derogatory, threatening, pornographic, sexually inappropriate, violent, abusive, harassing, hateful, racially, religiously or ethnically
offensive, or encourages, evidences or indicates conduct that would be considered a criminal offence, gives rise to civil liability, or violates any law;
(f) the entry will not contain viruses or cause injury or harm to any person or entity; and
(g) the entrant has not granted rights to their entry to any other person which is inconsistent with the rights granted to the Promoter.
28 Each entrant acknowledges that nothing in this promotion affects the rights of the Promoter or its corporate affiliates from developing and using ideas independently of those submitted in entries.
29 As a condition of accepting the Phase 1 Award, and without limiting clause 8, entrants agree to sign (if required by the Promoter) a statutory declaration regarding the originality of their entry.
30 As a condition of accepting the Phase 2 Award, and without limiting clause 14, entrants agree to sign (if required by the Promoter) a statutory declaration regarding the originality of their entry.
31 Each entrant acknowledges and agrees that if their entry wins an award, the Promoter (and each of its assignees and licensees) has the right, in its absolute discretion, to edit, amend, copy, use, publish, broadcast and
communicate to the public, the entry in any media including television and the internet, without any further consultation, reference, payment or any other compensation to the entrant.

17. 32 Each award winner must, at the Promoter’s request, participate in all promotional activity (such as publicity and photography) surrounding the winning of the award, free of charge, and they consent to the Promoter
using their name and image in promotional material in any medium throughout the world.
33 Each entrant must create their own entry and only submit an entry in their own name.
34 Once any award has left the Promoter’s/supplier’s premises, the Promoter and its agencies and companies associated with the competition will not be responsible for any delay in delivery, loss or damage to the
award.
35 The Promoter may require a winner to verify their entry and provide proof of identity, proof of age and proof of residency at the nominated award delivery address. Proof considered suitable for verification is at the
Promoter’s discretion.
36 For entrants who are affiliated with the Promoter’s customers or government agencies/institutions, additional diligence may be required prior to entering Phase 2 or executing the Collaboration Agreement.
37 If a winning entry is deemed not to comply with these conditions of entry, the entry will be discarded and an alternate winner will be selected. The judges’ decision is final and no correspondence will be entered into.
38 The Promoter may verify the validity of entries, and in its sole discretion, disqualify all entries from, and prohibit further participation in this competition by, any person or team who manipulates or tampers with or
benefits from any manipulation of or tampering with the entry process or the operation of the competition (including, but not limited to soliciting votes, disguising an IP address, using multiple email addresses or
aliases to submit multiple entries for the same person, or other electronic account) or acts in violation of these conditions, acts in a dishonest or disruptive manner, acts with the intent to annoy, abuse, threaten or
harass any other person, or acts in a way to jeopardise the fair operation of the competition.. The Promoter’s decision in relation to all aspects of the competition is final and no correspondence will be entered into.
39 Awards are not transferable or exchangeable. In the event for any reason a winner does not take an element of the award at the time stipulated by the Promoter then that element of the award will be forfeited by
the winner. Where an award is unavailable for any reason, the Promoter may substitute another item of equal or higher value as determined by the Promoter.
40 In the event of an award not being accepted or claimed, or refusal by the winner to execute a Collaboration Agreement, or due to a notified conflict of interest, the judges may elect to select an alternate winner with
the entry judged to be the next best entry to receive that award.
41 The Promoter reserves the right not to award the AU$100,000 if the judging panel do not deem any entry to be a winner
42 If for any reason any aspect of this competition is not capable of running as planned, including by reason of infection by computer virus, mobile network failure, bugs, tampering, manipulation, unauthorised
intervention, fraud, technical failures or any cause beyond the control of the Promoter which corrupts or affects the administration, security, fairness, integrity or proper conduct of this competition, the Promoter
may in its sole discretion cancel, terminate, modify or suspend the competition, or invalidate any affected entries.
43 The Promoter and its associated agencies and companies will not be liable for any loss (including, without limitation, indirect, special or consequential loss or loss of profits), expense, damage, personal injury or death
which is suffered or sustained (whether or not arising from any person’s negligence) in connection with this competition or accepting or using any award, except for any liability which cannot be excluded by law (in
which case that liability is limited to the minimum allowable by law).
44 The Promoter accepts no responsibility for any tax implications that may arise from the award winnings. Independent financial advice should be sought.
45 All times referred to in these terms and conditions are Australian Eastern Standard Time
46 The Promoter is Janssen-Cilag Pty Ltd, ABN: 47000129975, 66 Waterloo Road, Macquarie Park, NSW 2118 Australia.